View Rule
View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
HHS/FDA | RIN: 0910-AI95 | Publication ID: Spring 2024 |
Title: ●Sterility Requirements for Ophthalmic Preparations | |
Abstract:
The proposed rulemaking will revise 21 CFR 200.50 (Ophthalmic preparations and Dispensers) and 21 CFR 800.10 (Contact lens solutions; sterility) to (1) Remove historical and outdated language; (2) clarify the sterility requirements for ophthalmic preparations; and (3) establish additional requirements to ensure the safety of ophthalmic preparations packed in multiple-dose containers. |
|
Agency: Department of Health and Human Services(HHS) | Priority: Substantive, Nonsignificant |
RIN Status: First time published in the Unified Agenda | Agenda Stage of Rulemaking: Proposed Rule Stage |
Major: Undetermined | Unfunded Mandates: Undetermined |
CFR Citation: 21 CFR 200.50 21 CFR 800.10 21 CFR 349.3 (conforming revision) | |
Legal Authority: 21 U.S.C. 371(a) 21 U.S.C. 351(a)(2)(A),351(b), and 351(c) 21 U.S.C. 352(a), 352(c), and 352(j) 21 U.S.C. 360(e) |
Legal Deadline:
None |
||||||
Timetable:
|
Regulatory Flexibility Analysis Required: Undetermined | Government Levels Affected: None |
Federalism: No | |
Included in the Regulatory Plan: No | |
RIN Data Printed in the FR: No | |
Agency Contact: Elizabeth Anne Friedman Regulatory Counsel Department of Health and Human Services Food and Drug Administration 10903 New Hampshire Avenue, Building 51, Silver Spring, MD 20993 Phone:240 402-7930 Email: elizabeth.giaquinto@fda.hhs.gov |